BDNF protects neurons following injury by modulation of caspase activity

Neurocritical Care

Volumn 3, Issue 1, 2005, Pages 71-76

  Kim, Dong H ^a   Zhao, Xiurong ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Apoptosis; Caspase; CNS injury; Ischemia; Neurotrophin; Radiation injury

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMINYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLTYROSYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLASPARTYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BNEZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; ENZYME PRECURSOR; GLUCOSE; INTERLEUKIN 1BETA CONVERTING ENZYME; LACTATE DEHYDROGENASE; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; FEMALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INJURY; RAT; WESTERN BLOTTING;

ANIMALS; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASES; CEREBRAL CORTEX; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; NEURONS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 24644509224     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/Neurocrit.Care2005;3:71-76     Document Type: Article

References (29)

1. Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 1949;111:457-502.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
3. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999;399:A7-A14.
4. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000;17:927-938.
5. Beattie MS, Farooqui AA, Bresnahan JC. Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 2000;17:915-925.
6. Kim DH, Gutin PH, Noble LJ, Nathan D, Yu JS, Nockels RP. Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. Neuroreport 1996;7:2221-2225.
7. Koliatsos VE, Nauta HJ, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 1990;10(12):3801-3813.
8. Kim DH, Zhao Z, Tu CH, Casaccia-Bonnefil P, Chao MV. The neurotrophins prevent apoptotic but not necrotic cell death following neuronal injury by signaling through the trk receptor. J Neurosurg 2004;100:79-87.
9. Chao MV, Hempstead BL. p75 and Trk: a two-receptor system. Trends Neurosci 1995;18(7):321-326.
10. Eckenstein F. Transient expression of NGF-receptor-like immunoreactivity in postnatal rat brain and spinal cord. Brain Res 1988;446(1):149-154.
11. Ernfors P, Wetmore C, Olson L, Persson H. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 1990;5:511-526.
12. Mufson EJ, Brashers-Krug T, Kordower JH. p75 Nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord. Brain Res 1992;589:115-123.
13. Richardson PM, Verge Issa VMK, Riopelle RJ. Distribution of neuronal receptors for nerve growth factor in the rat. J Neurosci 1986;6(8):2312-2321.
14. Sofroniew MV, Howe CL, Mobley W. Nerve growth factor signaling, neuroprotection, and neural repair. Ann Rev Neurosci 2001;24:1217-1281.
15. Han BH, D'Acosta A, Back SA, et al. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 2000;7:38-53.
16. Kamens J, Paskind M, Hugunin M, et al. Identification and characterization of ICH-2, a novel member of the interleukin beta-coverting enzyme family of cysteine proteases. J Biol Chem 1995;270(25):15,250-15,256.
17. Munday NA, Vaillancourt JP, Ali A, et al. Molecular cloning and pro-apoptotic activity of ICEre1II and ICEre1III of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995;270(26): 15,870-15,876.
18. Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampalneurons in B27-supplemented neurobasal, anew serum-free medium combination. J Neurosci Res 1993;35:567-576.
19. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
20. Armstrong RC, Aja TJ, Hoang KD. Activation of the CED3/ICE-related protease caspace-3 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 1997;17:553-562.
21. Nath R, Raser KJ, Stafford D. Non-erythroid α-spectrin breakdown by calpain and interleukin 1-converting-enzyme-like protease in apoptotic cells, contributory roles of both protease families in neuronal apoptosis. Biochem J 1996;319:683-690.
22. Kuida K, Zheng TS, Na S. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368-372.
23. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspase contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 1997;17:7415-7424.
24. Chen J, Nagayama T, Jin K. Induction of caspace-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998;18:4914-4928.
25. Cheng Y, Deshmukeh M, D'Costa A. Caspace inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998;101:1992-1999.
26. Gillardon F, Kiprianova I, Sandkuhler J, Hossmann KA, Spranger M. Inhibition of caspase prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience 1999;93:1219-1222.
27. Namura S, Zhu J, Fink K. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998;18:3659-3668.
28. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischemic brain injury in interleukin-1 converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998;18:180-185.
29. Friedlander RM, Gagliardini V, Hara H. Expression of a dominant negative mutant of interleukin-1 converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 1997;185:933-940.